from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2739c/-

LFCtreatmentdescriptionclass of inhibitor

0.479

Amikacinug/mL Amikacintranslation

0.441

Cap5-10ug/mL Capreomycintranslation

0.661

Rox10-50 ug/mL Roxithromycintranslation

0.327

SM2-5 ug/mL Streptomycintranslation

0.261

Tet5-10 ug/mL Tetracyclinetranslation

-0.890

Rif0.2-5ug/mL Rifampicintranscription

0.058

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.885

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.682

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.483

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.595

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.451

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.311

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.334

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.577

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.356

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.188

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.305

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.886

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.276

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.757

KCN5-20 ug/mL Potassium cyaniderespiration

0.001

NaN30.2-2 mM Sodium aziderespiration

0.943

Nigericin50 uM Nigericinrespiration

-0.695

TRC10-150 ug/mL Triclosanrespiration

-2.243

TRZ10-25 ug/mL Thioridazinerespiration

-0.970

Valinomycin0.5-10 uM Valinomycinrespiration

-0.438

ZnSO42 mM ZnSO4respiration

0.063

menadione6-10 ug/mL Menadionerespiration

-0.209

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.477

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.101

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.537

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.292

NRP_1Non-replicating persistence stage 1dosRassociated

0.499

Amp0.2mg/mL AmpicillincellWall

0.411

Cephalexin20-100 ug/mL CephalexincellWall

0.771

Cerulenin0.32-5 ug/mL CerulenincellWall

0.514

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.263

EMB10-20 ug/mL EthambutolcellWall

0.512

Eta12-40 ug/mL EthionamidecellWall

0.419

INH0.2-0.4 ug/mL IsoniazidcellWall

0.209

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.113

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.237

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.304

BZA0.12 mg/mL BenzamidearomaticAmides

0.605

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.515

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.641

H2O24 mM hydrogen peroxideDNAdamaging

1.031

Levo10 ug/mL LevofloxacinDNAdamaging

0.847

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.672

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.305

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.511

UVUV-irradiationDNAdamaging

-1.463

ARP41-4 ug/mL Antitubercular compound ARP4?

0.025

Antimycin12.5-50 ug/mL Antimycin A?

0.065

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.561

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.502

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.337

PA8240.2-2 ug/mL PA-824?

-0.733

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.245

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.144

Verapamil50 uM Verapamil?

0.207

mercaptoethanol2 mM 2-Mercaptoethanol?

0.470

methoxatin10-20 ug/mL Methoxatin?